the generally accepted cell-killing effect of hydroxyurea ( hu ) on s-phase cells , as well as its potential to arrest cells at the g1/s boundary , hardly explain its benefit for application in human chronic myelogenous leukaemia .
C0020402
s-phase cells
C0023473
chronic myelogenous leukaemia